SX-682
Near Add Your Location
Accepting patients
SX-682
A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- CXCR1 Inhibitor
- CXCR2 Inhibitor
- Phase 1
- Has results
Showing 1-1 of 1